Company intelligence

DNA

Ginkgo Bioworks Holdings, Inc. · NYSE · Healthcare

Price$10.66+4.00% · +$0.41

Market cap696.36MEquity value

P / E-2.1Trailing ratio

Volume2.3MLatest session

Market data

DNA price chart

TradingView

Related signals

1 min delayed

Browse public DNA signals with their source context and measured market impact. Open any signal for its permanent analysis page.

DNAFeb 27, 2026-7.85% since signal

Ginkgo Bioworks Reports Weak Q4, Triggers Sell-Off in Stock

Ginkgo Bioworks faced a significant sell-off post its disappointing Q4 and full-year 2025 results, raising investor concerns about growth sustainability. The company may struggle to meet revenue targets, leading to a reevaluation of its stock value in the near term.

View signal analysis

DNAFeb 26, 2025-15.50% since signal

Flywire Posts Downbeat Results, Joins Lemonade, Ginkgo Bioworks And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

U.S. stock futures rose with Dow gaining around 100 points. Ginkgo Bioworks (DNA) shares fell 13% to $8.96 in pre-market trading. Ginkgo's quarterly results were weaker than expected, triggering a stock drop. CareDx Inc (CDNA) also experienced a significant drop of 18.1%. Weak performance in biotech affects investor sentiment towards related stocks.

View signal analysis

Research